A new gene-editing method may have the potential to advance regenerative medicine. This method could lead to breakthroughs in various fields, including cancer treatment, type 1 diabetes, collagen disorders, blood disorders, hearing loss, and sickle cell disease. The impact of this method is being explored in different areas, with some studies and therapies receiving new designations from the FDA.